Waters, Bruker Report Double-Digit Mass Spec Revenue Growth in Q2 | GenomeWeb

This story originally ran on July 28.

In second-quarter earnings calls this week, officials from Waters and Bruker each reported strong revenue growth in their companies' mass spectrometry businesses.

President and CEO Douglas Berthiaume said Waters' mass spec business was the firm's "strongest performer across the line" with revenue growth "well into the double-digits," and sales of high-end mass spectrometers like the company's Synapt series even stronger.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.